UNICA IRIS Institutional Research Information System

BALBONI, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 138.409
NA - Nord America 10.381
AS - Asia 1.251
AF - Africa 21
SA - Sud America 15
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 150.087
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 135.706
US - Stati Uniti d'America 10.348
UA - Ucraina 969
CN - Cina 832
SE - Svezia 625
GB - Regno Unito 381
FI - Finlandia 257
DE - Germania 226
SG - Singapore 181
FR - Francia 109
IN - India 91
VN - Vietnam 66
RU - Federazione Russa 56
CA - Canada 31
KR - Corea 26
BE - Belgio 21
NL - Olanda 15
HK - Hong Kong 12
IL - Israele 12
MU - Mauritius 12
ES - Italia 11
JP - Giappone 10
BR - Brasile 7
CL - Cile 6
PL - Polonia 6
AU - Australia 5
HU - Ungheria 5
IE - Irlanda 5
IQ - Iraq 5
NG - Nigeria 4
CZ - Repubblica Ceca 3
EU - Europa 3
LB - Libano 3
CH - Svizzera 2
KZ - Kazakistan 2
MA - Marocco 2
MX - Messico 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
RO - Romania 2
SN - Senegal 2
TW - Taiwan 2
AR - Argentina 1
AT - Austria 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
HR - Croazia 1
IR - Iran 1
KW - Kuwait 1
MC - Monaco 1
MY - Malesia 1
PE - Perù 1
PT - Portogallo 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 150.087
Salva come PNG Salva come JPEG
Città #
Cagliari 134.143
Fairfield 1.226
Woodbridge 1.039
Uta 1.036
Houston 1.035
Chandler 978
Boardman 732
Ashburn 704
Ann Arbor 538
Wilmington 521
Jacksonville 518
Seattle 498
Cambridge 465
Nyköping 353
Nanjing 184
Boston 169
Dearborn 131
Beijing 110
San Diego 99
Helsinki 97
Shanghai 83
Singapore 81
Milan 76
Dong Ket 66
Nanchang 57
Mountain View 56
Redwood City 52
Shenyang 52
Verona 52
Jiaxing 49
Ferrara 45
Rome 42
London 40
Hebei 38
Los Angeles 38
Pune 36
Washington 36
Falls Church 35
Changsha 34
Guangzhou 34
Norwalk 34
Tianjin 30
Sassari 28
Orange 26
New York 25
Saint Petersburg 21
Seoul 21
Jinan 20
Ningbo 20
Toronto 19
Paris 18
Olbia 17
Brussels 15
Tappahannock 13
Zhengzhou 12
Atlanta 11
Auburn Hills 11
Borås 11
Chicago 11
Indiana 11
Renton 11
Phoenix 10
Taizhou 10
Azor 9
Kilburn 9
Cedar Knolls 8
Central 8
Chapel Hill 8
Hefei 8
Champaign 7
Hangzhou 7
Hounslow 7
San Francisco 7
San Mateo 7
Wuhan 7
La Canada Flintridge 6
Naples 6
Budapest 5
Dublin 5
Far Rockaway 5
Frankfurt am Main 5
Fuzhou 5
Jinhua 5
Saint Louis 5
Villanovafranca 5
Wuxi 5
Barcelona 4
Chiswick 4
Clifton 4
Council Bluffs 4
Giarre 4
Nürnberg 4
Stabroek 4
Wandsworth 4
Augusta 3
Beirut 3
Bologna 3
Brampton 3
Brooklyn 3
Chengdu 3
Totale 146.182
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and evaluation of antiproliferative activity of new benzimidazolehydrazones 2.678
Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors 2.654
Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel 2.629
Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain 2.611
Dihydroquinazoline and Triazinedione Derivatives as Prok1 and Prok2 receptor antagonists in HEK-293 transfected cells 2.525
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 2.524
DIHYDROQUINAZOLINE BENZYLAMIDES AS ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE INHIBITORS 2.410
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 2.408
DESIGN, SYNTHESIS AND PHARMACOLOGICAL INVESTIGATION OF NEW DNA METHYLTRANSFERASE INHIBITORS 2.406
TRPV1 modulators: synthesis and in vitro evaluation of 1-heteroarylpiperidinecarboxamide and piperazinylurea derivatives 2.400
Attenuating Ischemic Disruption of K+ Homeostasis in the Cortex of Hypoxic-Ischemic Neonatal Rats: DOR Activation vs. Acupuncture Treatment 2.349
Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives 2.304
Critical role for prokineticin 2 in CNS autoimmunity 2.241
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity 2.190
3,4-Dihydroquinazoline derivatives inhibit the activities of cholinesterase enzymes 2.119
Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization 2.087
Benzofuran hydrazones as potential scaffold in the development of multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity 2.048
Indole derivatives as multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity of indole hydrazones 2.042
Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy 2.002
Antagonism of EG-VEGF receptors as targeted therapy for choriocarcinoma progression in vitro and in vivo 1.910
Synthesis and SIRT1 modulation studies of amides and hydrazides of benzoic acid incorporating a (2-trifluoromethylpyridin-4-yl)amino moiety 1.885
Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation 1.880
null 1.864
Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy 1.808
null 1.768
In-Vitro Evaluation of Antioxidant, Antiproliferative and Photo-Protective Activities of Benzimidazolehydrazone Derivatives 1.744
Interaction and reactivity of synthetic aminoisoflavones with metal-free and metalassociated amyloid-beta 1.719
PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice 1.715
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties 1.672
An important role for prokineticin 2 in autoimmune CNS demyelination 1.639
null 1.544
δ-Opioid Receptor Activation Attenuates Hypoxia/MPP+-Induced Downregulation of PINK1: a Novel Mechanism of Neuroprotection Against Parkinsonian Injury 1.518
Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro 1.462
Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease 1.454
Genetically Encodable Bacterial Flavin Transferase for Fluorogenic Protein Modification in Mammalian Cells 1.412
null 1.383
null 1.378
Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated 1.352
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model 1.312
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity 1.297
Prokineticin 2 promotes and sustains neuroinflammation in vincristine treated mice: Focus on pain and emotional like behavior 1.265
Antagonism of EG-VEGF receptors is a novel targeted therapy for choriocarcinoma progression: in vitro, in vivo and in clinical studies 1.251
Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins 1.229
Ligand- and cell-dependent determinants and cAMP modulation by delta opioid receptor (DOR) agonists 1.221
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system 1.149
A novel mechanism for cytoprotection against hypoxic injury: delta-opioid receptor-mediated increase in Nrf2 translocation 1.127
Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes 1.117
The antagonism of the prokineticin system counteracts bortezomib induced side effects: Focus on mood alterations 1.081
Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context 1.075
Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors 1.068
Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain 1.021
Prokineticin 1-prokineticin receptor 1 signaling promotes angiogenesis in the porcine endometrium during pregnancy 976
∂-opioid receptor activation protects against Parkinson’s disease-related mitochondrial dysfunction by enhancing PINK1/Parkin-dependent mitophagy 973
Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals 971
Opposite Roles of δ- and μ-Opioid Receptors in BACE1 Regulation and Alzheimer’s Injury 900
Evidence-Based View of Safety and Effectiveness of Prokineticin Receptors Antagonists during Pregnancy 880
Antidepressant-like and anxiolytic-like effects following activation of the mu-delta opioid receptor heteromer in the nucleus accumbens 843
null 825
Synthesis and Carbonic Anhydrase Inhibitory Activity of New 2-Aminochromenone Derivatives 801
δ‐Opioid receptors up‐regulate excitatory amino acid transporters in mouse astrocytes 754
Delta-opioid receptor activation modified microRNA expression in the rat kidney under prolonged hypoxia 749
activation of the mu-delta opioid receptor heteromer produces anti-depressant-like and anxiolytic-like effects 746
null 731
New features of the delta opioid receptor: conformationalproperties of deltorphin I analogues 729
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore 712
Synthesis and biological activity of prokineticin receptors antagonists and their development as a biomarker for imaging inflammatory pain 711
Prokineticin receptors antagonist PC-10 as a biomarker for imaging inflammatory pain 707
Effect of delta-opioid receptor activation on BDNF-TrkB vs. TNF-Alpha in the mouse cortex exposed to prolonged hypoxia 700
Agonists at the delta-opioid receptor modify the binding of mu-receptor agonists to the mu-delta receptor hetero-oligomer 692
Design, Synthesis and Evaluation of new 2-(Arylidenehydrazino)pyrrole Derivatives as Potential Antitumor Agents 663
Conformational dynamics of KIR3.1/KIR3.2 channel activation via delta-opioid receptors (DORs) 626
Ligands raise the constraint that limits constitutive activation in G protein-coupled opioid receptors 621
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues. 581
DOR activation inhibits anoxic/ischemic Na+ influx through Na+ channels via PKC mechanisms in the cortex 578
Structural and biological exploration of Phe3-Phe4-modified endomorphin-2 peptidomimetics 577
Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis 563
null 546
Blocking prokineticin receptors attenuates synovitis and joint destruction in collagen-induced arthritis 535
Hair Growth Promotion by δ-Opioid Receptor Activation 523
Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex 522
Influence of the side chain next to C-terminal benzimidazole in opioid pseudopeptides containing the Dmt-Tic pharmacophore 521
Na+ mechanism of delta-opioid receptor induced protection from K+ leakage in the cortex 519
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist, correlation between desensitization and tolerance 506
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues 502
Structure-activity relatioships of tetrapeptides related to dermorphin: a 500-MHz 1H-nmr study 501
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain 489
Hydrogen sulfide inhibits inflammatory pain and enhances the analgesic properties of delta opioid receptors 487
Role of the 2',6'-dimethyl-L-tyrosine (Dmt) in some opioid lead compounds 478
Orally administered H-Dmt-Tic-Lys-NH-CH2-Ph (MZ-2), a potent mu/delta-opioid receptor antagonist, regulates obese-related factors in mice 449
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic 438
Opioid peptides. Synthesis and binding properties of dermorphin related heptapeptides 432
Synthesis of Sulfonamides Incorporating Piperidinyl-Hydrazidoureido and Piperidinyl-Hydrazidothioureido Moieties and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity 429
Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism 422
Synthesis of N-FmocN,N'-bis-Boc-5-,6- and 8-guanyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid (5-GTIC, 6-GTIC and 8-GTIC) 416
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore 413
Opioid peptides. Synthesis and binding assays of desamino-Tyr1 dermorphin analogues. XII 411
Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides 408
Synthesis and opioid activity of [Sar4]dermorphin-tetrapeptide analogues 401
Opioid deltorphin C analogues containing cis- or-trans-2- or 3- or 4-aminocyclohexanecarboxylic acid residues 389
Dehydro-dermorphins. II. Synthesis and biological activity of unsatured dermorphin hexa and heptapeptides 387
Totale 120.680
Salva come PNG Salva come JPEG
Categoria #
all - tutte 204.868
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 204.868
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202020.098 0 0 266 871 7.484 5.154 2.809 719 645 594 579 977
2020/202130.722 1.251 938 1.418 7.715 5.734 3.390 2.804 1.789 791 1.628 1.745 1.519
2021/20229.546 600 806 1.092 529 420 819 912 643 595 587 934 1.609
2022/202316.522 1.658 1.741 1.164 1.262 1.464 2.157 1.168 1.527 978 1.019 1.601 783
2023/202419.214 725 818 712 1.288 1.898 3.050 3.230 1.222 924 1.297 1.763 2.287
2024/202523.682 8.850 11.727 3.105 0 0 0 0 0 0 0 0 0
Totale 150.654